Related Experiment Video

Updated: May 18, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Dyslipidemias in the prevention of cardiovascular disease: risks and causality

Ian Graham1, Marie-Therese Cooney, David Bradley

  • 1Department of Cardiology, Charlemont Clinic, Dublin, Ireland. ian@grahams.net

Current Cardiology Reports
|September 12, 2012
PubMed

Insights

Atherosclerotic cardiovascular disease (CVD) is a leading cause of death globally. Managing blood lipids like total cholesterol, LDL-cholesterol, HDL-cholesterol, and triglycerides is crucial for reducing CVD risk and improving patient outcomes.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Public Health

Background:

  • Atherosclerotic cardiovascular disease (CVD) remains the primary global cause of mortality.
  • Dyslipidemias significantly contribute to the widespread occurrence of CVD.
  • CVD risk is influenced by a combination of hyperlipidemia, hypertension, and smoking.

Purpose of the Study:

  • To review the causal relationships between lipid fractions and atherosclerotic cardiovascular disease.
  • To evaluate the therapeutic implications of lipid management in CVD prevention.
  • To assess the independent and combined roles of various lipid markers in CVD risk stratification.

Main Methods:

  • Review of epidemiological data and clinical trial evidence on lipid metabolism and CVD.
  • Analysis of the causal criteria for lipid fractions in relation to CVD risk.
  • Examination of the impact of therapeutic lipid reduction on cardiovascular outcomes.

Main Results:

  • Total blood cholesterol and LDL-cholesterol show a clear, graded, and causal relationship with CVD risk.
  • Therapeutic reduction of LDL-cholesterol is associated with improved cardiovascular outcomes.
  • HDL-cholesterol, triglycerides, and Lp(a) are associated with CVD, though causal evidence is less robust for triglycerides and Lp(a).

Conclusions:

  • Management of total and LDL-cholesterol is paramount for reducing atherosclerotic cardiovascular disease risk.
  • Triglyceride levels may indicate the need for comprehensive risk assessment, including obesity and glucose intolerance.
  • While Lp(a) is an inherited risk marker, its clinical impact may be mitigated by effective LDL-cholesterol lowering therapies.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...